Meme Kanseri Tedavisinde Elektrokemoterapi Uygulamaları

Siegel, R.L., K.D. Miller, H.E. Fuchs, Cancer Statistics, 2021. CA Cancer J Clin, 2021. 71(1): p. 7-33.

Kesson, E.M., G.M. Allardice, W.D. George, Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ, 2012. 344: p. e2718.

Lahmann, P.H., K. Hoffmann, N. Allen, Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer, 2004. 111(5): p. 762-71.

Lauby-Secretan, B., C. Scoccianti, D. Loomis, Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med, 2016. 375(8): p. 794-8.

Neuhouser, M.L., A.K. Aragaki, R.L. Prentice, Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. JAMA Oncol, 2015. 1(5): p. 611-21.

Key, T.J., P.N. Appleby, G.K. Reeves, Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst, 2003. 95(16): p. 1218-26.

Nelson, H.D., B. Zakher, A. Cantor, Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med, 2012. 156(9): p. 635-48.

Premenopausal Breast Cancer Collaborative, G., M.J. Schoemaker, H.B. Nichols, Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women. JAMA Oncol, 2018. 4(11): p. e181771.

Green, J., B.J. Cairns, D. Casabonne, Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol, 2011. 12(8): p. 785-94.

Ritte, R., A. Lukanova, A. Tjønneland, Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study. Int J Cancer, 2013. 132(11): p. 2619-29.

McCormack, V.A.,I. dos Santos Silva, Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 2006. 15(6): p. 1159-69.

Key, T.J., P.N. Appleby, G.K. Reeves, Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies. Steroids, 2015. 99(Pt A): p. 49-55.

Collaborative Group on Hormonal Factors in Breast, C., Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol, 2012. 13(11): p. 1141-51.

Liu, L., X. Hao, Z. Song, Correlation between family history and characteristics of breast cancer. Sci Rep, 2021. 11(1): p. 6360.

Moy, L., S.L. Heller, L. Bailey, ACR Appropriateness Criteria(®) Palpable Breast Masses. J Am Coll Radiol, 2017. 14(5s): p. S203-s224.

Miklavčič, D., B. Mali, B. Kos, Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online, 2014. 13(1): p. 29.

Sersa, G., M. Cemazar,D. Miklavcic, Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res, 1995. 55(15): p. 3450-5.

Mir, L.M., S. Orlowski, J. Belehradek, Jr., Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer, 1991. 27(1): p. 68-72.

Orlowski, S., J. Belehradek, Jr., C. Paoletti, Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol, 1988. 37(24): p. 4727-33.

Okino, M., H. Tomie, H. Kanesada, Optimal electric conditions in electrical impulse chemotherapy. Jpn J Cancer Res, 1992. 83(10): p. 1095-101.

Okino, M.,H. Mohri, Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn J Cancer Res, 1987. 78(12): p. 1319-21.

Neumann, E., M. Schaefer-Ridder, Y. Wang, Gene transfer into mouse lyoma cells by electroporation in high electric fields. Embo j, 1982. 1(7): p. 841-5.

Heller, L.,R. Heller, Heller LC, Heller RIn vivo electroporation for gene therapy. Hum Gene Ther 17: 890-897. Human gene therapy, 2006. 17: p. 890-7.

Davalos, R.V., I.L. Mir,B. Rubinsky, Tissue ablation with irreversible electroporation. Ann Biomed Eng, 2005. 33(2): p. 223-31.

Rubinsky, B., Irreversible electroporation in medicine. Technol Cancer Res Treat, 2007. 6(4): p. 255-60.

Maor, E., A. Ivorra,B. Rubinsky, Non Thermal Irreversible Electroporation: Novel Technology for Vascular Smooth Muscle Cells Ablation. PLOS ONE, 2009. 4(3): p. e4757.

Pech, M., A. Janitzky, J.J. Wendler, Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol, 2011. 34(1): p. 132-8.

Tracy, C.R., W. Kabbani,J.A. Cadeddu, Irreversible electroporation (IRE): a novel method for renal tissue ablation. BJU Int, 2011. 107(12): p. 1982-7.

Bagla, S.,D. Papadouris, Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report. J Vasc Interv Radiol, 2012. 23(1): p. 142-5.

Golberg, A.,M.L. Yarmush, Nonthermal irreversible electroporation: fundamentals, applications, and challenges. IEEE Trans Biomed Eng, 2013. 60(3): p. 707-14.

Cheung, W., H. Kavnoudias, S. Roberts, Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes. Technol Cancer Res Treat, 2013. 12(3): p. 233-41.

Sersa, G., D. Miklavcic, M. Cemazar, Electrochemotherapy in treatment of tumours. Eur J Surg Oncol, 2008. 34(2): p. 232-40.

Mali, B., T. Jarm, M. Snoj, Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol, 2013. 39(1): p. 4-16.

Miklavcic, D., M. Snoj, A. Zupanic, Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online, 2010. 9: p. 10.

Edhemovic, I., E.M. Gadzijev, E. Brecelj, Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat, 2011. 10(5): p. 475-85.

Miklavcic, D., G. Sersa, E. Brecelj, Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput, 2012. 50(12): p. 1213-25.

Teissie, J., N. Eynard, B. Gabriel, Electropermeabilization of cell membranes. Adv Drug Deliv Rev, 1999. 35(1): p. 3-19.

Rems, L.,D. Miklavcic, Tutorial: Electroporation of cells in complex materials and tissue. Journal of Applied Physics, 2016. 119: p. 201101.

Teissie, J., M. Golzio,M.P. Rols, Mechanisms of cell membrane electropermeabilization: A minireview of our present (lack of ?) knowledge. Biochimica et Biophysica Acta (BBA) - General Subjects, 2005. 1724(3): p. 270-280.

Weaver, J.C., Molecular basis for cell membrane electroporation. Ann N Y Acad Sci, 1994. 720: p. 141-52.

Chen, C., S.W. Smye, M.P. Robinson, Membrane electroporation theories: a review. Med Biol Eng Comput, 2006. 44(1-2): p. 5-14.

Casciola, M.,M. Tarek, A molecular insight into the electro-transfer of small molecules through electropores driven by electric fields. Biochim Biophys Acta, 2016. 1858(10): p. 2278-2289.

Rems, L., M. Tarek, M. Casciola, Properties of lipid electropores II: Comparison of continuum-level modeling of pore conductance to molecular dynamics simulations. Bioelectrochemistry, 2016. 112: p. 112-24.

Sozer, E.B., C.F. Pocetti,P.T. Vernier, Transport of charged small molecules after electropermeabilization - drift and diffusion. BMC Biophys, 2018. 11: p. 4.

Belehradek, J., Jr., S. Orlowski, L.H. Ramirez, Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta, 1994. 1190(1): p. 155-63.

Belehradek, M., C. Domenge, B. Luboinski, Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer, 1993. 72(12): p. 3694-700.

Gehl, J., Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand, 2003. 177(4): p. 437-47.

Gehl, J.,P.F. Geertsen, Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res, 2000. 10(6): p. 585-9.

Satkauskas, S., F. Andre, M.F. Bureau, Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer. Hum Gene Ther, 2005. 16(10): p. 1194-201.

Jiang, C., R.V. Davalos,J.C. Bischof, A review of basic to clinical studies of irreversible electroporation therapy. IEEE Trans Biomed Eng, 2015. 62(1): p. 4-20.

Scheffer, H.J., K. Nielsen, M.C. de Jong, Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol, 2014. 25(7): p. 997-1011; quiz 1011.

Moir, J., S.A. White, J.J. French, Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer. Eur J Surg Oncol, 2014. 40(12): p. 1598-604.

Rombouts, S.J., J.A. Vogel, H.C. van Santvoort, Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg, 2015. 102(3): p. 182-93.

Silk, M., D. Tahour, G. Srimathveeravalli, The state of irreversible electroporation in interventional oncology. Semin Intervent Radiol, 2014. 31(2): p. 111-7.

Scheltema, M.J., W. van den Bos, D.M. de Bruin, Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial. BMC Cancer, 2016. 16: p. 299.

Reddy, V.Y., J. Koruth, P. Jais, Ablation of Atrial Fibrillation With Pulsed Electric Fields: An Ultra-Rapid, Tissue-Selective Modality for Cardiac Ablation. JACC Clin Electrophysiol, 2018. 4(8): p. 987-995.

Wittkampf, F.H.M., R. van Es,K. Neven, Electroporation and its Relevance for Cardiac Catheter Ablation. JACC Clin Electrophysiol, 2018. 4(8): p. 977-986.

Escoffre, J.M.,M.P. Rols, Electrochemotherapy: progress and prospects. Curr Pharm Des, 2012. 18(23): p. 3406-15.

Sersa, G., B. Stabuc, M. Cemazar, Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur J Cancer, 1998. 34(8): p. 1213-8.

Gehl, J., T. Skovsgaard,L.M. Mir, Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs, 1998. 9(4): p. 319-25.

Jaroszeski, M.J., V. Dang, C. Pottinger, Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs, 2000. 11(3): p. 201-8.

Tarek, M., Membrane electroporation: a molecular dynamics simulation. Biophys J, 2005. 88(6): p. 4045-53.

Hu, Q., S. Viswanadham, R.P. Joshi, Simulations of transient membrane behavior in cells subjected to a high-intensity ultrashort electric pulse. Phys Rev E Stat Nonlin Soft Matter Phys, 2005. 71(3 Pt 1): p. 031914.

Delemotte, L.,M. Tarek, Molecular dynamics simulations of lipid membrane electroporation. J Membr Biol, 2012. 245(9): p. 531-43.

Heller, R., M. Jaroszeski, J. Leo-Messina, Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochemistry and Bioenergetics, 1995. 36(1): p. 83-87.

Jaroszeski, M.J., R.A. Gilbert,R. Heller, In vivo antitumor effects of electrochemotherapy in a hepatoma model. Biochim Biophys Acta, 1997. 1334(1): p. 15-8.

Pendas, S., M. Jaroszeski, R. Gilbert, Direct delivery of chemotherapeutic agents for the treatment of hepatomas and sarcomas in rat models. Radiology and Oncology, 1998. 32: p. 53-64.

Hyacinthe, M., M.J. Jaroszeski, V.V. Dang, Electrically enhanced drug delivery for the treatment of soft tissue sarcoma. Cancer, 1999. 85(2): p. 409-17.

Cemazar, M., D. Miklavcic,G. Sersa, Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Japanese journal of cancer research : Gann, 1998. 89(3): p. 328-333.

Cemazar, M., D. Miklavcic, L.M. Mir, Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model. Eur J Cancer, 2001. 37(9): p. 1166-72.

Miklavcic, D., K. Beravs, D. Semrov, The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J, 1998. 74(5): p. 2152-8.

Miklavcic, D., S. Corovic, G. Pucihar, Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. European Journal of Cancer Supplements, 2006. 4(11): p. 45-51.

Sersa, G., B. Stabuc, M. Cemazar, Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res, 2000. 6(3): p. 863-7.

Sersa, G., B. Stabuc, M. Cemazar, Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res, 2000. 10(4): p. 381-5.

Mir, L., J. Gehl, G. Sersa, Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin adminstered either systemically or locally and electric pulses delivered by the Cliniporator (TM) by means of invasive or non-invasive electrodes. EJC Supplements, 2006. 4: p. 14-25.

Sersa, G., T. Jarm, T. Kotnik, Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer, 2008. 98(2): p. 388-98.

Markelc, B., G. Sersa,M. Cemazar, Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PLOS ONE, 2013. 8(3): p. e59557.

Jarm, T., M. Cemazar, D. Miklavcic, Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther, 2010. 10(5): p. 729-46.

Snoj, M., M. Cemazar, T. Srnovrsnik, Limb sparing treatment of bleeding melanoma recurrence by electrochemotherapy. Tumori, 2009. 95(3): p. 398-402.

Sersˇa, G., D. Miklavcˇicˇ, M. Cˇemazˇar, Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompotent and immunodeficient mice. Bioelectrochemistry and Bioenergetics, 1997. 43(2): p. 279-283.

Muftuler, L.T., M.J. Hamamura, O. Birgul, In vivo MRI electrical impedance tomography (MREIT) of tumors. Technol Cancer Res Treat, 2006. 5(4): p. 381-7.

Sedlar, A., T. Dolinsek, B. Markelc, Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol, 2012. 46(4): p. 302-11.

Mir, L.M., L.F. Glass, G. Sersa, Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer, 1998. 77(12): p. 2336-42.

Campana, L.G., S. Mocellin, M. Basso, Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol, 2009. 16(1): p. 191-9.

Campana, L.G., S. Valpione, S. Mocellin, Electrochemotherapy for disseminated superficial metastases from malignant melanoma. Br J Surg, 2012. 99(6): p. 821-30.

Mali, B., D. Miklavcic, L.G. Campana, Tumor size and effectiveness of electrochemotherapy. Radiol Oncol, 2013. 47(1): p. 32-41.

Campana, L.G., D. Miklavcic, G. Bertino, Electrochemotherapy of superficial tumors - Current status:: Basic principles, operating procedures, shared indications, and emerging applications. Semin Oncol, 2019. 46(2): p. 173-191.

Gerlini, G., A. Tun-Kyi, C. Dudli, Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol, 2004. 165(6): p. 1853-63.

Jacobs, J.F., S. Nierkens, C.G. Figdor, Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy? Lancet Oncol, 2012. 13(1): p. e32-42.

Calvet, C.Y.,L.M. Mir, The promising alliance of anti-cancer electrochemotherapy with immunotherapy. Cancer Metastasis Rev, 2016. 35(2): p. 165-77.

Elliott, M.R., F.B. Chekeni, P.C. Trampont, Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature, 2009. 461(7261): p. 282-6.

Obeid, M., A. Tesniere, F. Ghiringhelli, Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med, 2007. 13(1): p. 54-61.

Andersson, U., H. Wang, K. Palmblad, High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med, 2000. 192(4): p. 565-70.

Scaffidi, P., T. Misteli,M.E. Bianchi, Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 2002. 418(6894): p. 191-5.

Cemazar, M., Y. Tamzali, G. Sersa, Electrochemotherapy in veterinary oncology. J Vet Intern Med, 2008. 22(4): p. 826-31.

Testori, A., G. Tosti, C. Martinoli, Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach. Dermatol Ther, 2010. 23(6): p. 651-61.

Marty, M., G. Sersa, J.R. Garbay, Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. European Journal of Cancer Supplements, 2006. 4(11): p. 3-13.

Gehl, J., G. Sersa, L.W. Matthiessen, Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol, 2018. 57(7): p. 874-882.

Rudolf, Z., B. Stabuc, M. Cemazar, Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients. Radiol Oncol, 1995. 29(6).

Heller, R., Treatment of cutaneous nodules using electrochemotherapy. J Fla Med Assoc, 1995. 82(2): p. 147-50.

Heller, R., M.J. Jaroszeski, D.S. Reintgen, Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer, 1998. 83(1): p. 148-57.

Larkin, J.O., C.G. Collins, S. Aarons, Electrochemotherapy: aspects of preclinical development and early clinical experience. Ann Surg, 2007. 245(3): p. 469-79.

Campana, L.G., G. Bianchi, S. Mocellin, Electrochemotherapy treatment of locally advanced and metastatic soft tissue sarcomas: results of a non-comparative phase II study. World J Surg, 2014. 38(4): p. 813-22.

Matthiessen, L.W., H.H. Johannesen, H.W. Hendel, Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol, 2012. 51(6): p. 713-21.

Gargiulo, M., M. Moio, G. Monda, Electrochemotherapy: actual considerations and clinical experience in head and neck cancers. Ann Surg, 2010. 251(4): p. 773.

Mozzillo, N., C. Caracò, S. Mori, Feasibility of neoadjuvant electrochemotherapy for a large metastatic lesion of the cheek in a patient with melanoma. European Journal of Surgical Oncology, 2012. 10(38): p. 999-1000.

Mozzillo, N., C. Caracò, S. Mori, Use of neoadjuvant electrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanoma. J Transl Med, 2012. 10: p. 131.

Carrera, C., A. Bennassar, P. Ishioka, Desmoplastic melanoma on the nose: electrochemotherapy as an alternative treatment to local advanced disease. J Eur Acad Dermatol Venereol, 2014. 28(4): p. 424-32.

Salwa, S.P., M.G. Bourke, P.F. Forde, Electrochemotherapy for the treatment of ocular basal cell carcinoma; a novel adjunct in the disease management. J Plast Reconstr Aesthet Surg, 2014. 67(3): p. 403-6.

NICE. Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma. 2014 [cited 2021; Available from: https://www.nice.org.uk/guidance/ipg478/resources/electrochemotherapy-for-primary-basal-cell-carcinoma-and-primary-squamous-cell-carcinoma-pdf-1899869938127557.

NICE. Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma. 2013 [cited 2021; Available from: https://www.nice.org.uk/guidance/ipg446/resources/electrochemotherapy-for-metastases-in-the-skin-from-tumours-of-nonskin-origin-and-melanoma-pdf-1899869753369797.

Linnert, M., H.K. Iversen,J. Gehl, Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy. Radiol Oncol, 2012. 46(4): p. 271-8.

Mahmood, F.,J. Gehl, Optimizing clinical performance and geometrical robustness of a new electrode device for intracranial tumor electroporation. Bioelectrochemistry, 2011. 81(1): p. 10-6.

Zagar, T.M., K.A. Higgins, E.F. Miles, Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy. Radiother Oncol, 2010. 97(3): p. 535-40.

Guarneri, V.,P. Conte, Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy. Oncologist, 2009. 14(7): p. 645-56.

Mir, L.M.,S. Orlowski, Mechanisms of electrochemotherapy. Adv Drug Deliv Rev, 1999. 35(1): p. 107-118.

Matthiessen, L.W., H.H. Johannesen, K. Skougaard, Dual time point imaging fluorine-18 flourodeoxyglucose positron emission tomography for evaluation of large loco-regional recurrences of breast cancer treated with electrochemotherapy. Radiol Oncol, 2013. 47(4): p. 358-65.

Lookingbill, D.P., N. Spangler,K.F. Helm, Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol, 1993. 29(2 Pt 1): p. 228-36.

Kreuter, A., T. van Eijk, P. Lehmann, Electrochemotherapy in advanced skin tumors and cutaneous metastases - a retrospective multicenter analysis. J Dtsch Dermatol Ges, 2015. 13(4): p. 308-15.

Spratt, D.E., E.A. Gordon Spratt, S. Wu, Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol, 2014. 32(28): p. 3144-55.

Matthiessen, L.W., M. Keshtgar, P. Curatolo, Electrochemotherapy for Breast Cancer-Results From the INSPECT Database. Clin Breast Cancer, 2018. 18(5): p. e909-e917.

Network, N.C.C. NCCN Clinical Practies Guidelines in Oncology (NCCN Guidelines) Breast Cancer Version 8.2021. 2021; Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.

Cabula, C., Neoadjuvant electrochemotherapy of breast cancer: our experience on first case treated in Italy. Updates in Surgery, 2013. 65(4): p. 325-328.